Anti-CHRNB1 antibodies are used in the immunodetection of the protein cholinergic receptor nicotinic beta 1 subunit. In humans, the canonical protein has a reported length of 501 amino acid residues and a mass of 56.7 kDa. Its subcellular localization is in the cell membrane. Up to 2 different isoforms have been reported for this protein. It is notably widely expressed in many tissue types. A member of the Ligand-gated ion channel (TC 1.A.9) protein family, CHRNB1 is known to be involved with chemical synaptic transmission and the transport of ions. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include CHRNB, CMS1D, CMS2A, CMS2C, SCCMS, and ACHRB. CHRNB1 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish and chimpanzee species. A number of CHRNB1 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.